Viridian completes subject enrolment for Phase III trial of TED treatment
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Viridian has completed enrolling subjects for a Phase III trial of its TED treatment. The trial has reached a milestone with the full enrollment of participants. The completion of subject enrollment suggests the trial is progressing to its next stage.